{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:36:36Z","timestamp":1787502996185,"version":"build-2736575974"},"reference-count":84,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Ovarian cancer is one of the most common malignancies among women worldwide. The course of the disease is often latent and asymptomatic in the early stages, but as it develops, metastasis occurs, accompanied by accumulation of ascites in the peritoneal cavity. The ascites fluid constitutes a specific microenvironment influencing the processes of carcinogenesis. In ascites, signaling is mediated by various cytokines that control tumor cell proliferation, progression, metastasis, and chemoresistance. Adipokines, secreted into ascites and also appearing in blood, may be markers of ongoing processes related to the development of neoplastic disease. Moreover, a significant influence of adipocyte lipids on the growth of tumors, for which they are one of energy sources, is observed. Adiponectin, interleukin 6 (IL-6), interleukin 8 (IL-8), monocyte chemotactic protein-1 (MCP-1) and tissue inhibitor of metalloproteinase-1 (TIMP-1), discussed in the present review, were found to mediate the effects of omentum metastasis through homing, migration and invasion of ovarian cancer cells. Further research on those adipokines seem to be a natural consequence, allowing for a better understanding of the mechanisms of neoplastic disease and determination of the treatment procedure.<\/jats:p>","DOI":"10.3390\/cancers13184702","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T07:52:14Z","timestamp":1632124334000},"page":"4702","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Characteristics of Selected Adipokines in Ascites and Blood of Ovarian Cancer Patients"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7887-132X","authenticated-orcid":false,"given":"Marcin","family":"Wr\u00f3blewski","sequence":"first","affiliation":[{"name":"Department of Medical Biology and Biochemistry, Faculty of Medicine, Collegium Medicum of Nicolaus Copernicus University, ul. Kar\u0142owicza 24, 85-092 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8123-3882","authenticated-orcid":false,"given":"Karolina","family":"Szewczyk-Golec","sequence":"additional","affiliation":[{"name":"Department of Medical Biology and Biochemistry, Faculty of Medicine, Collegium Medicum of Nicolaus Copernicus University, ul. Kar\u0142owicza 24, 85-092 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0986-5604","authenticated-orcid":false,"given":"Iga","family":"Ho\u0142y\u0144ska-Iwan","sequence":"additional","affiliation":[{"name":"Laboratory of Electrophysiology of Epithelial Tissue and Skin, Department of Pathobiochemistry and Clinical Chemistry, Faculty of Pharmacy, Collegium Medicum of Nicolaus Copernicus University, ul. M. Curie Sk\u0142odowskiej 9, 85-094 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8188-8296","authenticated-orcid":false,"given":"Joanna","family":"Wr\u00f3blewska","sequence":"additional","affiliation":[{"name":"Department of Medical Biology and Biochemistry, Faculty of Medicine, Collegium Medicum of Nicolaus Copernicus University, ul. Kar\u0142owicza 24, 85-092 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4492-4796","authenticated-orcid":false,"given":"Alina","family":"Wo\u017aniak","sequence":"additional","affiliation":[{"name":"Department of Medical Biology and Biochemistry, Faculty of Medicine, Collegium Medicum of Nicolaus Copernicus University, ul. Kar\u0142owicza 24, 85-092 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,20]]},"reference":[{"key":"ref_1","unstructured":"(2020, July 13). Cancer Burden Statistics and Trends Across Europe | European Cancer Information System. Available online: https:\/\/ecis.jrc.ec.europa.eu\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA. Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","article-title":"Rethinking Ovarian Cancer: Recommendations for Improving Outcomes","volume":"11","author":"Vaughan","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian Tumorigenesis","volume":"164","author":"Shih","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1002\/cncr.29524","article-title":"Abridged republication of FIGO\u2019s staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"121","author":"Prat","year":"2015","journal-title":"Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10555-013-9456-2","article-title":"Ovarian cancer microenvironment: Implications for cancer dissemination and chemoresistance acquisition","volume":"33","author":"Thibault","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Chen, F., Zhuang, X., Lin, L., Yu, P., Wang, Y., Shi, Y., Hu, G., and Sun, Y. (2015). New horizons in tumor microenvironment biology: Challenges and opportunities. BMC Med., 13.","DOI":"10.1186\/s12916-015-0278-7"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nature06916","article-title":"Mining the plasma proteome for cancer biomarkers","volume":"452","author":"Hanash","year":"2008","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s13238-017-0466-7","article-title":"Revisiting ovarian cancer microenvironment: A friend or a foe?","volume":"9","author":"Zhang","year":"2018","journal-title":"Protein Cell"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Klymenko, Y., and Nephew, K.P. (2018). Epigenetic crosstalk between the tumor microenvironment and ovarian cancer cells: A therapeutic road less traveled. Cancers, 10.","DOI":"10.3390\/cancers10090295"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4093\/dmj.2012.36.5.317","article-title":"Clinical relevance of adipokines","volume":"36","year":"2012","journal-title":"Diabetes Metab. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.5604\/01.3001.0012.1329","article-title":"Ovarian cancer and inflammation. Part 1. Pro-inflammatory cytokines","volume":"8","author":"Terlikowska","year":"2018","journal-title":"Prog. Health Sci."},{"key":"ref_13","first-page":"34","article-title":"Brunatna tkanka t\u0142uszczowa u doros\u0142ego cz\u0142owieka: Wyst\u0119powanie i funkcja (Brown adipose tissue in adult humans: Distribution and function)","volume":"7","year":"2011","journal-title":"Endokrynol. Oty\u0142o\u015b\u0107 Zaburzenia Przemiany Mater."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2012.08.036","article-title":"Functional and structural features of adipokine family","volume":"61","author":"Raucci","year":"2013","journal-title":"Cytokine"},{"key":"ref_15","first-page":"1","article-title":"Food ingredients involved in white-to-brown adipose tissue conversion and in calorie burning","volume":"10","author":"Vettor","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1530\/EJE-13-0945","article-title":"White, brown and pink adipocytes: The extraordinary plasticity of the adipose organ","volume":"170","author":"Giordano","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"ref_17","first-page":"16","article-title":"Tkanka t\u0142uszczowa i jej rola w odporno\u015bci\u2014Nowe dane","volume":"17","year":"2012","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/prca.201100052","article-title":"Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders","volume":"6","author":"Lehr","year":"2012","journal-title":"Proteomics Clin. Appl."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2217\/clp.09.86","article-title":"Do adipokines link obesity to its related metabolic and cardiovascular diseases?","volume":"5","year":"2010","journal-title":"J. Clin. Lipidol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.amjmed.2008.10.015","article-title":"\u201cSick Fat\u201d, Metabolic Disease and Atherosclerosis","volume":"122","author":"Bays","year":"2009","journal-title":"Am. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"S\u0142omian, G., Nowak, D., Buczkowska, M., G\u0142ogowska-Gruszka, A., S\u0142omian, S.P., Roczniak, W., Janyga, S., and Nowak, P. (2019). The role of adiponectin and leptin in the treatment of ovarian cancer patients. Endokrynol. Pol.","DOI":"10.5603\/EP.a2018.0081"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5468\/ogs.2016.59.4.279","article-title":"Association of plasma adiponectin and leptin levels with the development and progression of ovarian cancer","volume":"59","author":"Jin","year":"2016","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_24","first-page":"2875","article-title":"Ovarian Cancer-associated Ascites Demonstrates altered immune environment-2009","volume":"29","author":"Giuntoli","year":"2009","journal-title":"Anticancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s13402-016-0289-1","article-title":"Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells","volume":"39","author":"Uruski","year":"2016","journal-title":"Cell. Oncol."},{"key":"ref_26","first-page":"2365","article-title":"(Wang Xinbo); Wang, X. (Wang Xiaoli); Sun, H. Prognostic value of serum IL-8 and IL-10 in patients with ovarian cancer undergoing chemotherapy","volume":"17","author":"Zhang","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/08820139.2017.1360342","article-title":"Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer","volume":"46","author":"Sanguinete","year":"2017","journal-title":"Immunol. Investig."},{"key":"ref_28","first-page":"498","article-title":"Comparison of VEGF, IL-8 and \u03b2-FGF concentrations in the serum and ascites of patients with ovarian cancer, Por\u00f3wnanie st\u0119\u017ce\u0144 VEGF, IL-8 oraz \u03b2-FGF w surowicy krwi i p\u0142ynie otrzewnowym u pacjentek leczonych z powodu raka jajnika","volume":"82","author":"Grabiec","year":"2011","journal-title":"Ginekol. Pol."},{"key":"ref_29","first-page":"1","article-title":"Immune profiling and identification of prognostic immune-related risk factors in human ovarian cancer","volume":"8","author":"Klynning","year":"2019","journal-title":"Oncoimmunology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.bjc.6690776","article-title":"Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients","volume":"81","author":"Hefler","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"24584","DOI":"10.1074\/jbc.M112275200","article-title":"Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18\/pulmonary and activation-regulated chemokine in ovarian carcinoma","volume":"277","author":"Schutyser","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1471-2407-10-139","article-title":"TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients","volume":"10","author":"Mahner","year":"2010","journal-title":"BMC Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.4314\/tjpr.v17i11.5","article-title":"Adiponectin exhibits proliferative and anti-apoptotic effects on ovarian cancer cells via PI3K\/AKT and Raf\/MEK\/ERK pathways","volume":"17","author":"Feng","year":"2018","journal-title":"Trop. J. Pharm. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1471-2407-11-210","article-title":"Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients","volume":"11","author":"Lane","year":"2011","journal-title":"BMC Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-1511-7","article-title":"Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers","volume":"15","author":"Lane","year":"2015","journal-title":"BMC Cancer"},{"key":"ref_36","first-page":"471","article-title":"Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions","volume":"8","author":"Menkiszak","year":"2015","journal-title":"OncoTargets Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-59009-z","article-title":"Pre-operative sera interleukin-6 in the diagnosis of high-grade serous ovarian cancer","volume":"10","author":"Kampan","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_38","first-page":"566","article-title":"Profiling of cytokines in human epithelial ovarian cancer ascites","volume":"2","author":"Matte","year":"2012","journal-title":"Am. J. Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2873030","DOI":"10.1155\/2017\/2873030","article-title":"Markers of Oxidative Stress and Inflammation in Ascites and Plasma in Patients with Platinum-Sensitive, Platinum-Resistant, and Platinum-Refractory Epithelial Ovarian Cancer","volume":"2017","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1111\/j.1582-4934.2008.00408.x","article-title":"Interleukin-6 and leptin as markers of energy metabolicchanges in advanced ovarian cancer patients","volume":"13","author":"Madeddu","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"ref_41","unstructured":"(2020, July 13). UniProt. Available online: https:\/\/www.uniprot.org\/."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"40352","DOI":"10.1074\/jbc.M300365200","article-title":"Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin","volume":"278","author":"Waki","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Achari, A.E., and Jain, S.K. (2017). Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18061321"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.metabol.2011.04.008","article-title":"Effects of leptin and adiponectin on pancreatic \u03b2-cell function","volume":"60","author":"Lee","year":"2011","journal-title":"Metabolism"},{"key":"ref_45","first-page":"13","article-title":"Zr\u00f3\u017cnicowanie fenotypowe i funkcjonalne makrofag\u00f3w w kontek\u015bcie ich wp\u0142ywu na odpowied\u017a przeciwnowotworow\u0105","volume":"2","author":"Kowalska","year":"2016","journal-title":"Rev. Res. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00125-012-2598-x","article-title":"Adiponectin: Mechanistic insights and clinical implications","volume":"55","author":"Turer","year":"2012","journal-title":"Diabetologia"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1074\/jbc.M109.088708","article-title":"Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype","volume":"285","author":"Ohashi","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"520","DOI":"10.7150\/ijbs.8879","article-title":"Macrophage Polarization in Inflammatory Diseases","volume":"10","author":"Liu","year":"2014","journal-title":"Int. J. Biol. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"13460","DOI":"10.1074\/jbc.M110.204644","article-title":"Molecular mechanism for adiponectin-dependent M2 macrophage polarization: Link between the metabolic and innate immune activity of full-length adiponectin","volume":"286","author":"Mandal","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1615\/CritRevEukaryotGeneExpr.2016015920","article-title":"de M.M.; Minari, A.L.A.; dos Santos, R.V.T.; Neto, J.C.R.; Lira, F.S. Macrophage Polarization: Implications on Metabolic Diseases and the Role of Exercise","volume":"26","author":"Silveira","year":"2016","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Gelsomino, L., Naimo, G.D., Catalano, S., Mauro, L., and And\u00f2, S. (2019). The emerging role of adiponectin in female malignancies. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092127"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/bjc.2015.245","article-title":"Obesity and survival among women with ovarian cancer: Results from the Ovarian Cancer Association Consortium","volume":"113","author":"Nagle","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(14)60892-8","article-title":"Body-mass index and risk of 22 specific cancers: A population-based cohort study of 5.24 million UK adults","volume":"384","author":"Bhaskaran","year":"2014","journal-title":"Lancet"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/intimm\/dxq030","article-title":"IL-6: From its discovery to clinical applications","volume":"22","author":"Kishimoto","year":"2010","journal-title":"Int. Immunol."},{"key":"ref_55","first-page":"24","article-title":"Interleukina 6\u2014Znaczenie biologiczne i rola w patogenezie reumatoidalnego zapalenia staw\u00f3w","volume":"47","author":"Kontny","year":"2009","journal-title":"Reumatologia"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2337\/db06-1656","article-title":"Systemic Inflammation in Obese Humans","volume":"56","author":"Fontana","year":"2007","journal-title":"Diabetes"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ctrv.2012.04.007","article-title":"Interleukin-6 signaling pathway in targeted therapy for cancer","volume":"38","author":"Guo","year":"2012","journal-title":"Cancer Treat. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2012.04.013","article-title":"Interleukin-8 secretion by ovarian cancer cells increases anchorage-independent growth, proliferation, angiogenic potential, adhesion and invasion","volume":"59","author":"Wang","year":"2012","journal-title":"Cytokine"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/07357907.2014.898156","article-title":"Interleukin-8 and interleukin-17 for cancer","volume":"32","author":"Zarogoulidis","year":"2014","journal-title":"Cancer Invest."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/jcmm.14848","article-title":"IL-8 promotes cell migration through regulating EMT by activating the Wnt\/\u03b2-catenin pathway in ovarian cancer","volume":"24","author":"Wen","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","article-title":"The interleukin-8 pathway in cancer","volume":"14","author":"Waugh","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_62","first-page":"2317","article-title":"IL-6 prevents CXCL8-induced stimulation of EpCAM expression in ovarian cancer cells","volume":"19","author":"Popek","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_63","first-page":"4521","article-title":"Identification of interleukin 8 as an inhibitor of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in the ovarian carcinoma cell line OVCAR3","volume":"63","author":"Abdollahi","year":"2003","journal-title":"Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-020-00624-9","article-title":"Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS)","volume":"13","author":"Farkas","year":"2020","journal-title":"J. Ovarian Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): An overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interf. Cytokine Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10456-011-9244-y","article-title":"Down-modulation of TNFSF15 in ovarian cancer by VEGF and MCP-1 is a pre-requisite for tumor neovascularization","volume":"15","author":"Deng","year":"2012","journal-title":"Angiogenesis"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4049\/jimmunol.164.2.733","article-title":"Defective Expression of the Monocyte Chemotactic Protein-1 Receptor CCR2 in Macrophages Associated with Human Ovarian Carcinoma","volume":"164","author":"Sica","year":"2000","journal-title":"J. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/cmi.2017.135","article-title":"The chemokine MCP-1 (CCL2) in the host interaction with cancer: A foe or ally?","volume":"15","author":"Yoshimura","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"117435","DOI":"10.1016\/j.lfs.2020.117435","article-title":"The role of Toll-like receptor 4 signaling pathway in ovarian, cervical, and endometrial cancers","volume":"247","author":"Lupi","year":"2020","journal-title":"Life Sci."},{"key":"ref_70","first-page":"4785","article-title":"MCP-1 promotes invasion and adhesion of human ovarian cancer cells","volume":"33","author":"Furukawa","year":"2013","journal-title":"Anticancer Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"85291","DOI":"10.18632\/oncotarget.13300","article-title":"Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment","volume":"7","author":"Alexander","year":"2016","journal-title":"Oncotarget"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1172\/JCI117933","article-title":"The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer","volume":"95","author":"Negus","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3390\/cancers4030701","article-title":"Ovarian cancer stroma: Pathophysiology and the roles in cancer development","volume":"4","author":"Furuya","year":"2012","journal-title":"Cancers"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1590\/1414-431x20176104","article-title":"Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer","volume":"50","author":"Zhang","year":"2017","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Escalona, R.M., Chan, E., Kannourakis, G., Findlay, J.K., and Ahmed, N. (2018). The many facets of metzincins and their endogenous inhibitors: Perspectives on ovarian cancer progression. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020450"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1097-0215(19981029)78:3<331::AID-IJC13>3.0.CO;2-9","article-title":"Proteinase requirements of epidermal growth factor\u2013induced ovarian cancer cell invasion","volume":"78","author":"Ellerbroek","year":"1998","journal-title":"Int. J. Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1038\/sj.onc.1210093","article-title":"Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion","volume":"26","author":"Sengupta","year":"2007","journal-title":"Oncogene"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Sonego, M., Poletto, E., Pivetta, E., Nicoloso, M.S., Pellicani, R., Vinciguerra, G.L.R., Citron, F., Sorio, R., Mongiat, M., and Baldassarre, G. (2020). TIMP-1 Is Overexpressed and Secreted by Platinum Resistant Epithelial Ovarian Cancer Cells. Cells, 9.","DOI":"10.3390\/cells9010006"},{"key":"ref_79","first-page":"673","article-title":"Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary","volume":"17","author":"Sakata","year":"2000","journal-title":"Int. J. Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/gyno.2000.5806","article-title":"Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors","volume":"77","author":"Huang","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0304-3835(97)00295-4","article-title":"Positive correlation between inhibitors of matrix metalloproteinase 1 and matrix metalloproteinases in malignant ovarian tumor tissues","volume":"120","author":"Kikkawa","year":"1997","journal-title":"Cancer Lett."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.7150\/thno.37549","article-title":"Dual-platform affinity proteomics identifies links between the recurrence of ovarian carcinoma and proteins released into the tumor microenvironment","volume":"9","author":"Finkernagel","year":"2019","journal-title":"Theranostics"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"\u017divadinovi\u0107, R., Petri\u0107, A., Krtini\u0107, D., Dini\u0107, S.P.-T., and \u017divadinovi\u0107, B. (2017). Ascitic Fluid in Ovarian Carcinoma\u2014From Pathophysiology to the Treatment. Ascites\u2014Physiopathology, Treatment, Complications and Prognosis, IntechOpen.","DOI":"10.5772\/intechopen.70476"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3892\/or.2011.1608","article-title":"Expression of MMP-2,-7,-9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer","volume":"27","author":"Brun","year":"2012","journal-title":"Oncol. Rep."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/18\/4702\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:02:26Z","timestamp":1760166146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/18\/4702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":84,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["cancers13184702"],"URL":"https:\/\/doi.org\/10.3390\/cancers13184702","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,20]]}}}